Crossmark Global Holdings Inc. Buys 517 Shares of Balchem Co. (NASDAQ:BCPC)

Crossmark Global Holdings Inc. increased its holdings in Balchem Co. (NASDAQ:BCPC) by 20.5% during the third quarter, HoldingsChannel reports. The fund owned 3,034 shares of the basic materials company’s stock after acquiring an additional 517 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Balchem were worth $534,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Vanguard Group Inc. raised its holdings in shares of Balchem by 3.8% in the 1st quarter. Vanguard Group Inc. now owns 3,935,935 shares of the basic materials company’s stock worth $609,873,000 after acquiring an additional 144,423 shares during the last quarter. Conestoga Capital Advisors LLC raised its holdings in shares of Balchem by 1.8% in the 3rd quarter. Conestoga Capital Advisors LLC now owns 1,175,569 shares of the basic materials company’s stock worth $206,900,000 after acquiring an additional 20,360 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Balchem by 0.9% in the 2nd quarter. Dimensional Fund Advisors LP now owns 697,461 shares of the basic materials company’s stock worth $107,372,000 after acquiring an additional 5,977 shares during the last quarter. Congress Asset Management Co. raised its holdings in shares of Balchem by 12.4% in the 3rd quarter. Congress Asset Management Co. now owns 301,440 shares of the basic materials company’s stock worth $53,053,000 after acquiring an additional 33,373 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its holdings in shares of Balchem by 1.2% in the 2nd quarter. Bank of New York Mellon Corp now owns 277,475 shares of the basic materials company’s stock worth $42,717,000 after acquiring an additional 3,279 shares during the last quarter. Institutional investors and hedge funds own 87.91% of the company’s stock.

Balchem Trading Up 0.5 %

NASDAQ:BCPC opened at $177.77 on Friday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.90 and a current ratio of 2.98. The firm has a market cap of $5.78 billion, a price-to-earnings ratio of 47.79, a price-to-earnings-growth ratio of 5.30 and a beta of 0.65. Balchem Co. has a 52 week low of $120.76 and a 52 week high of $186.03. The firm has a 50-day moving average price of $172.71 and a two-hundred day moving average price of $165.59.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. StockNews.com upgraded shares of Balchem from a “hold” rating to a “buy” rating in a report on Monday, October 28th. HC Wainwright increased their price objective on shares of Balchem from $185.00 to $190.00 and gave the company a “buy” rating in a research note on Monday, November 4th.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.